Molbio Diagnostics IPO: Price Band ₹768-₹807, Opens Aug 10
Source: Mint Markets
Arth Insight · What this means for your wallet
- You have the opportunity to invest a minimum of ₹13,824 to buy shares in this healthcare company.
- This is a chance to potentially grow your money if the company performs well after its stock market debut.
- Investing in IPOs carries risks; you could lose money if the share price falls after listing.
Molbio Diagnostics has announced its Initial Public Offering (IPO) with a price band set between ₹768 and ₹807 per share. The subscription period will be open from August 10 to August 12.
- ▸Molbio Diagnostics IPO price band is ₹768-₹807 per share.
- ▸The IPO subscription opens on August 10 and closes on August 12.
- ▸The minimum investment for retail investors is ₹13,824 for 18 shares.
- ✓Molbio Diagnostics IPO price band is ₹768-₹807 per share.
- ✓The IPO subscription opens on August 10 and closes on August 12.
- ✓The minimum investment for retail investors is ₹13,824 for 18 shares.
Molbio Diagnostics Limited has officially set the price band for its upcoming Initial Public Offering (IPO), inviting investors to subscribe between ₹768 and ₹807 per equity share. The subscription window for the public issue will open on August 10 and close on August 12, 2023. Anchor investors will have the opportunity to place their bids on August 7.
The minimum lot size for retail investors has been fixed at 18 shares, meaning the minimum investment would be ₹13,824 (18 shares x ₹768). While the total issue size is yet to be disclosed, the price band provides a clear indication of the valuation the company is seeking from the market.
Molbio Diagnostics is a significant player in the diagnostics sector, known for its innovative point-of-care testing solutions. The company's focus on developing and manufacturing molecular diagnostic instruments and reagents has positioned it as a key contributor to healthcare accessibility, particularly in remote areas.
This IPO presents an opportunity for retail investors to participate in the growth story of a company operating in the rapidly expanding healthcare and diagnostics market in India. Investors are advised to carefully review the company's financials, future prospects, and the Red Herring Prospectus (RHP) before making any investment decisions.
This information is for educational purposes only and does not constitute investment advice.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.
Frequently Asked Questions
What is the price band for the Molbio Diagnostics IPO?
The price band for the Molbio Diagnostics IPO is set between ₹768 and ₹807 per equity share.
When will the Molbio Diagnostics IPO open and close?
The IPO subscription will open on August 10, 2023, and will close on August 12, 2023.
What is the minimum investment required for retail investors?
The minimum lot size is 18 shares, making the minimum investment ₹13,824 (18 shares x ₹768).
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about Stock Market
US Treasury Gears Up for Major Issuance Overhaul Post-Bessent Intervention
The US Treasury Department is preparing for a significant overhaul of its guidance for issuing government bonds, marking the biggest change since early 2024. This move follows Treasury Secretary Scott Bessent's recent willingness to intervene in the bond market to reduce yields, signaling a more active approach to managing government debt.
BreakingNifty Reclaims 23,000 Mark as FIIs Invest ₹6,304.67 Crore
The Indian stock market witnessed a strong surge recently, with the Nifty 50 index surpassing the crucial 23,000 level. This upswing was significantly boosted by Foreign Institutional Investors (FIIs), who injected a substantial ₹6,304.67 crore into Indian equities, alongside a rise in the Sensex.
Nifty Jumps 2.59%, Sensex Rises 1.83% as Pharma, Healthcare Lead Rally
Indian benchmark indices, Nifty and Sensex, recorded significant gains today, rising 2.59% and 1.83% respectively. The strong upward movement was primarily driven by robust performance in the pharmaceutical and healthcare sectors.
Related Stories
US Treasury Gears Up for Major Issuance Overhaul Post-Bessent Intervention
The US Treasury Department is preparing for a significant overhaul of its guidance for issuing government bonds, marking the biggest change since early 2024. This move follows Treasury Secretary Scott Bessent's recent willingness to intervene in the bond market to reduce yields, signaling a more active approach to managing government debt.
BreakingNifty Reclaims 23,000 Mark as FIIs Invest ₹6,304.67 Crore
The Indian stock market witnessed a strong surge recently, with the Nifty 50 index surpassing the crucial 23,000 level. This upswing was significantly boosted by Foreign Institutional Investors (FIIs), who injected a substantial ₹6,304.67 crore into Indian equities, alongside a rise in the Sensex.
Nifty Jumps 2.59%, Sensex Rises 1.83% as Pharma, Healthcare Lead Rally
Indian benchmark indices, Nifty and Sensex, recorded significant gains today, rising 2.59% and 1.83% respectively. The strong upward movement was primarily driven by robust performance in the pharmaceutical and healthcare sectors.
AI Hype Falters: Tech Stocks Dip on Earnings Misses
Global tech stocks faced pressure on Friday as disappointing earnings from major Wall Street companies fueled concerns about the sustainability of the AI investment boom. Investors are scrutinizing the actual demand and profitability of AI technologies.